<code id='84D619E3AA'></code><style id='84D619E3AA'></style>
      • <acronym id='84D619E3AA'></acronym>
      <center id='84D619E3AA'><center id='84D619E3AA'><tfoot id='84D619E3AA'></tfoot></center><abbr id='84D619E3AA'><dir id='84D619E3AA'><tfoot id='84D619E3AA'></tfoot><noframes id='84D619E3AA'>
      • <optgroup id='84D619E3AA'><strike id='84D619E3AA'><sup id='84D619E3AA'></sup></strike><code id='84D619E3AA'></code></optgroup>
        5. <b id='84D619E3AA'><label id='84D619E3AA'><select id='84D619E3AA'><dt id='84D619E3AA'><span id='84D619E3AA'></span></dt></select></label></b><u id='84D619E3AA'></u>
          <i id='84D619E3AA'><strike id='84D619E3AA'><tt id='84D619E3AA'><pre id='84D619E3AA'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / hotspot / hotspot      
           
     
           
      
          hotspot 
           
      
           
      
           
       2025-09-30 16:07:25 
   
      
           
      
           
                        
          hotspot  
          
                                   
                 
                                      author：knowledge   
                                        
                                      
                                      Page View：84743
                                  
                                    
          
                                   
          Franklin faces
          Adobe
          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.
          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.
          advertisement
          Arch declined to comment on the new fundraising.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          Diversity in clinical trials starts with building trust, experts say
                                
                            
          Next article：  
                                      
                                          23andMe had bad news about my health. I wish a person had delivered it
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles